FDA Inspection
CSL Behring AGCSL Behring AG – FDA Inspection, Apr 13, 2018
Record Details
This FDA Inspection record concerns CSL Behring AG, with an inspection on April 13, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f926487f-2e44-4432-98c7-9602dc241d81
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1057840
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of CSL Behring AG
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2020 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 29, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 19, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 2, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 19, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Behring AG
- FDA Inspection 1121637 - 2020-02-18
- FDA Inspection 990288 - 2016-09-29
- FDA Inspection 890258 - 2014-06-19
- FDA Inspection 769044 - 2012-02-02
- FDA Inspection 645082 - 2010-01-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.